Gentaur Molecular Products

Best Molecular Products Supplier

Doxorubicin hydrochloride

Background: Many a long time of analysis demonstrates that the presence of and perceived high quality of the parent-child bond can impression a toddler’s well being, psychological well being, and interpersonal trajectory for a lifetime (Weinfield, Sroufe, Egeland, & Carlson, 1999 Handbook of attachment: Idea, analysis, and medical functions.

Doxorubicin hydrochloride

New York: Guilford Press, 68; Lieberman, Toddler Psychological Well being Journal, 25, 336, 2004). Nevertheless, investigations relating to the utility of strategies to guage the standard and nature of caregiver-child interactions are restricted. Utilizing medical information from 151 caregiver-child dyads, this examine examines the psychometric properties of the Crowell Downside Fixing Process Score Scale utilizing exploratory issue evaluation. Moreover, the predictive validity of the coding system was examined by way of comparisons with the Guardian-Toddler Relationship International Evaluation Scale (PIRGAS).
Findings: The kid and grownup scales had been every psychometrically outlined by a single issue that was internally constant and well-defined conceptually by the consultant gadgets. Excessive inner consistency for every scale supplies help for the reliability of the ranking scale, and means that the Crowell scores might be helpful as two separate scales measuring a toddler’s affective presentation and caregiver responsiveness, but additionally collectively as a complete rating assessing general relational functioning. Facets of the caregiver-child relationship had been considerably associated to PIRGAS scores on the kid and grownup domains.
Conclusions: The outcomes of this examine recommend the Crowell Downside Fixing Process Score Scale is a quick instrument, with good inner consistency, that may assess a variety of younger youngsters, in a medical setting.
Key phrases: Attachment; caregiver; youngster improvement; relationships.

Rising Prevalence of Multidrug-Resistant Candida haemulonii Species Advanced amongst All Yeast Cultures Collected by a Reference Laboratory over the Previous 11 Years

  • There may be worldwide concern with the growing charges of infections attributable to multiresistant Candida isolates reported in tertiary medical facilities. We checked for historic traits when it comes to prevalence charges and antifungal susceptibility of the Candida haemulonii species complicated in our yeast inventory tradition collected over the last 11 years.
  • The isolates had been recognized by sequencing the rDNA inner transcribed spacer (ITS) area, and antifungal susceptibility checks for amphotericin B, voriconazole, fluconazole, anidulafungin, and 5-fluorocytosine had been carried out by the Medical and Laboratory Requirements Institute (CLSI) microbroth methodology. A complete of 49 isolates had been recognized as Candida haemulonii sensu stricto (n = 21), adopted by C.
  • haemulonii var. vulnera (n = 15) and C. duobushaemulonii (n = 13), together with 38 isolates cultured from sufferers with deep-seated Candida infections. The prevalence of the C.
Doxorubicin hydrochloride
GA4969-100MG 100 mg
EUR 181
Doxorubicin hydrochloride
GA4969-10MG 10 mg
EUR 78
Doxorubicin hydrochloride
GA4969-25MG 25 mg
EUR 98
Doxorubicin hydrochloride
GA4969-50MG 50 mg
EUR 126
Doxorubicin Hydrochloride
20-abx076623
  • EUR 342.00
  • EUR 787.00
  • 10 mg
  • 50 mg
  • Shipped within 5-12 working days.
Doxorubicin hydrochloride
TNC00267 20mg Ask for price
Doxorubicin hydrochloride USP
D005-10MG 10 mg
EUR 166
Doxorubicin hydrochloride USP
D005-25MG 25 mg
EUR 301
Doxorubicin Hydrochloride (Autophagy inducer)
SIH-390-10MG 10 mg
EUR 193
  • Doxorubicin Hydrochloride is used in a clinical setting for the treatment of a wide range of cancers, including lymphomas, leukemias, and solid tumors of the breast, pancreas, stomach, bladder, and ovaries. This drug intercalates into DNA and therefo
  • Show more
Description: The substance Doxorubicin Hydrochloride is a autophagy inducer. It is synthetically produced and has a purity of >98%. The pure substance is red solid which is soluble in water (50 mM)..
Doxorubicin Hydrochloride (Autophagy inducer)
SIH-390-50MG 50 mg
EUR 529
  • Doxorubicin Hydrochloride is used in a clinical setting for the treatment of a wide range of cancers, including lymphomas, leukemias, and solid tumors of the breast, pancreas, stomach, bladder, and ovaries. This drug intercalates into DNA and therefo
  • Show more
Description: The substance Doxorubicin Hydrochloride is a autophagy inducer. It is synthetically produced and has a purity of >98%. The pure substance is red solid which is soluble in water (50 mM)..
Erlotinib, Hydrochloride Salt
1588-100
EUR 169
Erlotinib, Hydrochloride Salt
1588-1000
EUR 398
Doxorubicin
ADC-P-013 unit Ask for price
Doxorubicin
HY-15142A 100mg
EUR 215
Doxorubicin
abx188695-1g 1 g
EUR 467
  • Shipped within 1-2 weeks.
Doxorubicin
A3966-10 10 mg
EUR 108
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin
A3966-100 100 mg
EUR 235
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin
A3966-25 25 mg
EUR 131
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin
A3966-5.1 10 mM (in 1mL DMSO)
EUR 131
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin
A3966-S Evaluation Sample
EUR 81
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin
D063-100MG 100 mg
EUR 1051
Doxorubicin
D063-25MG 25 mg
EUR 322
Erlotinib, Hydrochloride Salt, >99%
BC026-101 1g
EUR 273
Erlotinib, Hydrochloride Salt, >99%
BC026-102 2g
EUR 388
Erlotinib, Hydrochloride Salt, >99%
BC026-105 5g
EUR 570
Adriamycin (Doxorubicin)
E1KS1208 10mg
EUR 409
Doxorubicin HCl
20-abx184016
  • EUR 746.00
  • EUR 1483.00
  • 1 g
  • 5 g
  • Shipped within 1-2 weeks.
Doxorubicin 10mM
TG4120 0.25ml
EUR 156
17-DMAG, Hydrochloride Salt, >98%
BC024-001 1mg
EUR 178
17-DMAG, Hydrochloride Salt, >98%
BC024-005 5mg
EUR 286
17-DMAG, Hydrochloride Salt, >98%
BC024-010 10mg
EUR 408
17-DMAG, Hydrochloride Salt, >98%
BC024-025 25mg Ask for price
17-DMAG, Hydrochloride Salt, >99%
BC024-100 100mg Ask for price
17-DMAG, Hydrochloride Salt, >99%
BC024-101 1g Ask for price
17-DMAG, Hydrochloride Salt, >99%
BC024-250 250mg Ask for price
OSU-03012, Hydrochloride Salt, >98%
BC061-005 5mg
EUR 313
OSU-03012, Hydrochloride Salt, >98%
BC061-025 25mg
EUR 529
Doxorubicin (Adriamycin) HCl
A1832-10 10 mg
EUR 125
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin (Adriamycin) HCl
A1832-100 100 mg
EUR 467
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin (Adriamycin) HCl
A1832-25 25 mg
EUR 189
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin (Adriamycin) HCl
A1832-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas.
Doxorubicin HCl, 100mg
R2531-100mg
EUR 1300
Doxorubicin HCl, 10mg
R2531-10mg
EUR 197
Anti-EGFR-doxorubicin ADC
ADC-W-600 1mg Ask for price
Description: This ADC product is comprised of an anti-EGFR monoclonal antibody conjugated via a linker to a doxorubicin
Anti-CD22-DIBO-doxorubicin ADC
ADC-W-339 1mg Ask for price
Description: This ADC product is comprised of an anti-CD22 monoclonal antibody conjugated via a DIBO linker to a doxorubicin
Anti-TNFRSF8 (cAC10)-DIBO-doxorubicin ADC
ADC-W-406 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a DIBO linker to a doxorubicin
Anti-ERBB2 (Trastuzumab)-NGM-doxorubicin ADC
ADC-W-412 1mg Ask for price
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a NGM linker to adoxorubicin
Anti-EGFR (cetuximab)-SMCC-Doxorubicin ADC
ADC-W-504 1mg Ask for price
Description: This ADC product is comprised of an anti-EGFR monoclonal antibody (cetuximab) conjugated via a SMCC linker to Doxorubicin
Anti-EpCAM (MOC31)-hydrazone-Doxorubicin ADC
ADC-W-581 1mg Ask for price
Description: This ADC product is comprised of an anti-EPCAM monoclonal antibody (MOC31) conjugated via a hydrazone linker to Doxorubicin
Anti-FUT3 (clone cBR96)-hydrazone-doxorubicin ADC
ADC-W-423 1mg Ask for price
Description: This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone cBR96) conjugated via a hydrazone linker to adoxorubicin
Anti-CD70 (clone h1F6)-β-glucuronide-doxorubicin ADC
ADC-W-376 1mg Ask for price
Description: This ADC product is comprised of an anti-CD70 monoclonal antibody (clone h1F6) conjugated via a β-glucuronide linker to a doxorubicin
Bile salt
BB0225 25g
EUR 79.58
  • Product category: Biochemicals/Detergents/Surfactants
Anti-TNFRSF8 (cCA10)-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC
ADC-W-353 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cCA10) conjugated via a β-glucuronide linker to a doxorubicin propyloxazoline (DPO)
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Doxorubicin Stimulated
HCL-2004 100ug
EUR 225
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Doxorubicin Stimulated
HCL-2010 100ug
EUR 213
Stachydrine (hydrochloride)
C3648-100 100 mg
EUR 119
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits.
Stachydrine (hydrochloride)
C3648-1000 1 g
EUR 467
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits.
Stachydrine (hydrochloride)
C3648-250 250 mg
EUR 206
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits.
Stachydrine (hydrochloride)
C3648-500 500 mg
EUR 328
Description: Stachydrine is an anti-metastatic agent.Stachydrine, a pyrrolidine betaine, was first isolated from seed husk and the pulp of the fruit of C. Leonurus, and many other Asian plants and fruits.
Barnidipine (hydrochloride)
C3727-100 100 mg
EUR 203
Description: Barnidipine is a calcium-channel blocker.A calcium channel, an ion channel which displays selective permeability to calcium ions, is sometimes synonymous as voltage-dependent calcium channel, although there are also ligand-gated calcium channels.
Barnidipine (hydrochloride)
C3727-50 50 mg
EUR 155
Description: Barnidipine is a calcium-channel blocker.A calcium channel, an ion channel which displays selective permeability to calcium ions, is sometimes synonymous as voltage-dependent calcium channel, although there are also ligand-gated calcium channels.
MS049 (hydrochloride)
C3776-10 10 mg
EUR 200
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor.
MS049 (hydrochloride)
C3776-100 100 mg
EUR 1181
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor.
MS049 (hydrochloride)
C3776-25 25 mg
EUR 382
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor.
MS049 (hydrochloride)
C3776-5 5 mg
EUR 139
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor.
MS049 (hydrochloride)
C3776-5.1 10 mM (in 1mL DMSO)
EUR 150
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor.
MS049 (hydrochloride)
C3776-50 50 mg
EUR 653
Description: IC50: 34 nM for PRMT4; 43 nM for PRMT6 MS049 is a dual PRMT4 and PRMT6 inhibitor.
Guanabenz (hydrochloride)
C3786-100 100 mg
EUR 231
Description: Guanabenz is an orally active ?2-adrenoceptor agonist with hypotensive effects [1]. The ?2 adrenergic receptors belong to a family of G protein-coupled receptor (GPCR), mediate many physiological actions of the endogenous catecholamines adrenaline and noradrenaline.
Guanabenz (hydrochloride)
C3786-50 50 mg
EUR 144
Description: Guanabenz is an orally active ?2-adrenoceptor agonist with hypotensive effects [1]. The ?2 adrenergic receptors belong to a family of G protein-coupled receptor (GPCR), mediate many physiological actions of the endogenous catecholamines adrenaline and noradrenaline.
Ulixertinib (hydrochloride)
C3921-10 10 mg
EUR 406
Description: Ulixertinib, also named as BVD-523, is a novel and reversible inhibitor of ERK1/2. Ulixertinib potently and selectively inhibits the activity of ERK1 and ERK2 kinases in a reversible, ATP-competitive fashion [1].
Ulixertinib (hydrochloride)
C3921-25 25 mg
EUR 661
Description: Ulixertinib, also named as BVD-523, is a novel and reversible inhibitor of ERK1/2. Ulixertinib potently and selectively inhibits the activity of ERK1 and ERK2 kinases in a reversible, ATP-competitive fashion [1].
Ulixertinib (hydrochloride)
C3921-5 5 mg
EUR 250
Description: Ulixertinib, also named as BVD-523, is a novel and reversible inhibitor of ERK1/2. Ulixertinib potently and selectively inhibits the activity of ERK1 and ERK2 kinases in a reversible, ATP-competitive fashion [1].
Chlorcyclizine (hydrochloride)
C3989-100 100 mg
EUR 118
Description: Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1]. The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking.
Chlorcyclizine (hydrochloride)
C3989-1000 1 g
EUR 595
Description: Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1]. The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking.
Chlorcyclizine (hydrochloride)
C3989-250 250 mg
EUR 210
Description: Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1]. The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking.
Chlorcyclizine (hydrochloride)
C3989-500 500 mg
EUR 357
Description: Chlorcyclizine is a phenylpiperazine antagonist for histamine H1 receptor [1]. The histamine has been involved in modulating many physiological functions of the hypothalamus, such as arousal state, feeding, locomotor activity, and drinking.
  • haemulonii species complicated elevated from 0.9% (18 isolates amongst 1931) within the first interval (December 2008 to June 2013) to 1.7% (31 isolates amongst 1868) within the second interval (July 2014 to December 2019) of research (p = 0.047).
  • All isolates examined exhibited excessive minimal inhibition concentrations for amphotericin B and fluconazole, however they remained inclined to 5-fluorocytosine and anidulafungin. We had been capable of display the elevated isolation of the multiresistant Candida haemulonii species complicated in our tradition assortment, the place most isolates had been cultured from sufferers with deep-seated infections.

Key phrases: Candida haemulonii species complicated; antifungal resistance; candidemia; cryptic Candida species; nosocomial fungal infections.

Erlotinib, Hydrochloride Salt

We report on a thermally steady monolithic Doppler uneven spatial heterodyne (DASH) interferometer with field-widening prisms for thermospheric wind measurements by observing the Doppler shift of the airglow emission.

gel casting base 20 cm
EVS1300-BASE ea
EUR 200

gel casting base for evs3100
EVS3100-BASE ea
EUR 301

gel casting base for evs3200
EVS3200-BASE ea
EUR 301

gel casting base for evs3300
EVS3300-BASE ea
EUR 301

Carubicin (Free base)
B1853-1
EUR 153

Carubicin (Free base)
B1853-5
EUR 457

FIPI (free base)
B2372-25
EUR 631

FIPI (free base)
B2372-5
EUR 196

Terbinafine (Free base)
B2423-250
EUR 207

Terbinafine (Free base)
B2423-50
EUR 120

MCC950 (Free base)
B1031-1
EUR 153

MCC950 (Free base)
B1031-5
EUR 457

Apatinib (Free base)
B1613-25
EUR 414

Apatinib (Free base)
B1613-5
EUR 142

AZD4547, Free Base
ADC-P-063 unit Ask for price

AZD8055, Free Base
ADC-P-064 unit Ask for price

Cyclopamine, Free Base
ADC-P-079 unit Ask for price

Ixabepilone, Free Base
ADC-P-104 unit Ask for price

R406(free base)
E1KS1533 2mg
EUR 521

RPR107393 free base
HY-100299 1mg
EUR 481

FR167344 free base
HY-100301 1mg
EUR 2637

FR183998 free base
HY-100302 1mg
EUR 1127

FR194738 free base
HY-100303 1mg
EUR 1990

Vatalanib (free base)
HY-10203 5mg
EUR 119

Masupirdine (free base)
HY-109118 1mg
EUR 223

R406 (free base)
HY-11108 10mM/1mL
EUR 231

ITI214 (free base)
HY-12501 100mg
EUR 2943

AS2863619 (free base)
HY-126675 5mg
EUR 1175

AZD3839 (free base)
HY-13438 50mg
EUR 1014

Ripasudil free base
HY-15685A 10mg
EUR 408

YM158 (free base)
HY-U00355 1mg
EUR 2309

THZ1 (Free base)
9664-25
EUR 1023

THZ1 (Free base)
9664-5
EUR 294

LY2835219 free base
A3575-100 100 mg
EUR 572
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base
A3575-25 25 mg
EUR 258
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base
A3575-5 5 mg
EUR 142
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

R406 (free base)
A5880-100 100 mg
EUR 1210
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)
A5880-25 25 mg
EUR 514
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)
A5880-5 5 mg
EUR 166
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)
A5880-5.1 10 mM (in 1mL DMSO)
EUR 264
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)
A5880-S Evaluation Sample
EUR 81
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

Rucaparib (free base)
A8893-10 10 mg
EUR 200
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)
A8893-200 200 mg
EUR 1036
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)
A8893-5 5 mg
EUR 137
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)
A8893-5.1 10 mM (in 1mL DMSO)
EUR 142
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)
A8893-50 50 mg
EUR 456
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Lapatinib, Free base
2138-100
EUR 387

Lapatinib, Free base
2138-25
EUR 191

Ruxolitinib, Free base
2139-100 Ask for price

Ruxolitinib, Free base
2139-25
EUR 533

Ruxolitinib, Free base
2139-5
EUR 207

Imatinib, Free base
2141-100
EUR 147

Imatinib, Free base
2141-1000
EUR 419

Linsitinib, Free base
2294-25
EUR 566

Linsitinib, Free base
2294-5
EUR 185

Tipifarnib, Free base
2296-1
EUR 142

Tipifarnib, Free base
2296-5
EUR 414

Vatalanib, Free Base
2026-25
EUR 305

Vatalanib, Free Base
2026-5
EUR 126

Erlotinib, Free Base
2048-100
EUR 158

Erlotinib, Free Base
2048-1000
EUR 387

Sunitinib, Free base
2097-100
EUR 191

Sunitinib, Free base
2097-1000
EUR 501

Sunitinib, Free base
2097-25
EUR 115

Xylazine (free base)
Q-1445.0025 25.0g
EUR 321
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7]

PLX5622 (free base)
B2965-25 25 mg
EUR 753

PLX5622 (free base)
B2965-5 5 mg
EUR 227

TMB free base
TB0954 1g
EUR 70.88
  • Product category: Biochemicals/Indicators/Stains/Immuno Related

BMS-345541 (Free base)
B1907-1
EUR 142

BMS-345541 (Free base)
B1907-5
EUR 414

UNC-926, free base
B2158-25
EUR 631

UNC-926, free base
B2158-5
EUR 196

SB-334867 free base
B3423-100 100 mg
EUR 599
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-25 25 mg
EUR 290
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-5 5 mg
EUR 128
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-5.1 10 mM (in 1mL DMSO)
EUR 131
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

GSK J4 free base
B5959-10 10 mg
EUR 373
Description: GSK J4 free base

Analytical deduction and numerical simulation are utilized to find out the central optical path distinction, the thermal compensation situation and the field-widening design. A monolithic interferometer with optimized configuration was constructed and examined within the laboratory.

Laboratory checks present that the very best visibility of 0.94 was realized with the 9 ° field-of-view illumination, whereas the thermal responses of the spatial frequency and the optical section offset are 0.0154 cm-1/°C and 0.469 rad/°C, respectively.